Burkholderia cenocepacia in cystic fibrosis: Epidemiology and molecular mechanisms of virulence

Clinical Microbiology and Infection

Volumn 16, Issue 7, 2010, Pages 821-830

  Drevinek, P ^a   Mahenthiralingam, E ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Burkholderia cepacia; Epidemiology; Genomics; Multilocus; Review; Sequence typing; Virulence factors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; IRON; POLYMYXIN DERIVATIVE; POLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTION; BURKHOLDERIA MULTIVORANS; CANADA; CYSTIC FIBROSIS; EPIDEMIOLOGICAL DATA; EUROPE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SEQUENCE; HUMAN; INFLAMMATION; MOLECULAR MECHANICS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; TRANSCRIPTOMICS;

BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA MULTIVORANS;

EID: 77954636950     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03237.x     Document Type: Review

References (83)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003, 168:918-951.
2. Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 2005, 3:144-156.
3. Vanlaere E, Baldwin A, Gevers D. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 2009, 59:102-111.
4. Vanlaere E, Lipuma JJ, Baldwin A. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol 2008, 58:1580-1590.
5. Baldwin A, Mahenthiralingam E, Drevinek P. Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis 2007, 13:458-461.
6. Biddick R, Spilker T, Martin A. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett 2003, 228:57-62.
7. Jones AM, Dodd ME, Govan JR. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004, 59:948-951.
8. Coenye T, LiPuma JJ. Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis. J Infect Dis 2002, 185:1454-1462.
9. Drevinek P, Vosahlikova S, Cinek O. Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic. J Med Microbiol 2005, 54:655-659.
10. Chen JS, Witzmann KA, Spilker T. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 2001, 139:643-649.
11. Johnson WM, Tyler SD, Rozee KR. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 1994, 32:924-930.
12. Speert DP, Henry D, Vandamme P. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002, 8:181-187.
13. Holden MT, Seth-Smith HM, Crossman LC. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 2009, 191:261-277.
14. Mahenthiralingam E, Drevinek P. Comparative genomics of Burkholderia species. Burkholderia molecular microbiology and genomics 2007, 53-79. Coenye T, Vandamme P. In, eds, Wymondham, Horizon Bioscience
15. LiPuma JJ, Spilker T, Gill LH. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001, 164:92-96.
16. Mahenthiralingam E, Vandamme P, Campbell ME. Infection with Burkholderia cepacia Complex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can Replace Burkholderia multivorans. Clin Infect Dis 2001, 33:1469-1475.
17. Mahenthiralingam E, Bischof J, Byrne SK. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000, 38:3165-3173.
18. Isles A, Maclusky I, Corey M. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984, 104:206-210.
19. Drevinek P, Baldwin A, Lindenburg L. Oxidative stress of Burkholderia cenocepacia induces insertion sequence-mediated genomic rearrangements that interfere with macrorestriction-based genotyping. J Clin Microbiol 2010, 48:34-40.
20. Vandamme P, Holmes B, Coenye T. Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res Microbiol 2003, 154:91-96.
21. Coenye T, Spilker T, Van Schoor A. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax 2004, 59:952-954.
22. Golini G, Cazzola G, Fontana R. Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre. Eur J Clin Microbiol Infect Dis 2006, 25:175-180.
23. Baldwin A, Mahenthiralingam E, Drevinek P. Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol 2008, 46:290-295.
24. Govan JR, Brown AR, Jones AM. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2007, 2:153-164.
25. Saiman L, Siegel J. Infection control in cystic fibrosis. Clin Microbiol Rev 2004, 17:57-71.
26. Baldwin A, Mahenthiralingam E, Thickett KM. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 2005, 43:4665-4673.
27. Mahenthiralingam E, Campbell ME, Henry DA. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 1996, 34:2914-2920.
28. Govan JR, Brown PH, Maddison J. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342:15-19.
29. Graindorge A, Menard A, Neto M. Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit. Diagn Microbiol Infect Dis 2010, 66:29-40.
30. Bylund J, Campsall PA, Ma RC. Burkholderia cenocepacia induces neutrophil necrosis in chronic granulomatous disease. J Immunol 2005, 174:3562-3569.
31. Pier GB, Grout M, Zaidi TS. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 1996, 271:64-67.
32. McClean S, Callaghan M. Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 2009, 58:1-12.
33. Leiske DL, Karimpour-Fard A, Hume PS. A comparison of alternative 60-mer probe designs in an in-situ synthesized oligonucleotide microarray. BMC Genomics 2006, 7:72.
34. Coenye T, Drevinek P, Mahenthiralingam E. Identification of putative noncoding RNA genes in the Burkholderia cenocepacia J2315 genome. FEMS Microbiol Lett 2007, 276:83-92.
35. Drevinek P, Holden MT, Ge Z. Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infect Dis 2008, 8:121.
36. O'Grady EP, Viteri DF, Malott RJ. Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC Genomics 2009, 10:441.
37. Yoder-Himes DR, Chain PS, Zhu Y. Mapping the Burkholderia cenocepacia niche response via high-throughput sequencing. Proc Natl Acad Sci USA 2009, 106:3976-3981.
38. Baldwin A, Sokol PA, Parkhill J. The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun 2004, 72:1537-1547.
39. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997, 35:808-816.
40. Malott RJ, Baldwin A, Mahenthiralingam E. Characterization of the cciIR quorum-sensing system in Burkholderia cenocepacia. Infect Immun 2005, 73:4982-4992.
41. Lewenza S, Conway B, Greenberg EP. Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol 1999, 181:748-756.
42. Malott RJ, O'Grady EP, Toller J. A Burkholderia cenocepacia orphan LuxR homolog is involved in quorum-sensing regulation. J Bacteriol 2009, 191:2447-2460.
43. Eberl L. Quorum sensing in the genus Burkholderia. Int J Med Microbiol 2006, 296:103-110.
44. Visser MB, Majumdar S, Hani E. Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect Immun 2004, 72:2850-2857.
45. Goldberg JB. Polysaccharides of Burkholderia spp. Burkholderia molecular microbiology and genomics 2007, 93-110. Coenye TVandamme P. In, eds, Wymondham, Horizon Bioscience
46. Loutet SA, Flannagan RS, Kooi C. A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 2006, 188:2073-2080.
47. Hunt TA, Kooi C, Sokol PA. Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 2004, 72:4010-4022.
48. Ortega X, Hunt TA, Loutet S. Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol 2005, 187:1324-1333.
49. Saldias MS, Ortega X, Valvano MA. Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J Med Microbiol 2009, 58:1542-1548.
50. Chiarini L, Cescutti P, Drigo L. Exopolysaccharides produced by Burkholderia cenocepacia recA lineages IIIA and IIIB. J Cyst Fibros 2004, 3:165-172.
51. Moreira LM, Videira PA, Sousa SA. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide. Biochem Biophys Res Commun 2003, 312:323-333.
52. Conway BA, Chu KK, Bylund J. Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. J Infect Dis 2004, 190:957-966.
53. Burns JL. Antibiotic Resistance of Burkholderia spp. Burkholderia molecular microbiology and genomics 2007, 81-92. Coenye TVandamme P. In, eds, Wymondham, Horizon Bioscience
54. Guglierame P, Pasca MR, De Rossi E. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol 2006, 6:66.
55. Nair BM, Cheung KJ, Griffith A. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest 2004, 113:464-473.
56. Poole K, Heinrichs DE, Neshat S. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine. Mol Microbiol 1993, 10:529-544.
57. Buroni S, Pasca MR, Flannagan RS. Assessment of three resistance-nodulation-cell division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol 2009, 9:200.
58. Tomich M, Herfst CA, Golden JW. Role of flagella in host cell invasion by Burkholderia cepacia. Infect Immun 2002, 70:1799-1806.
59. Sajjan US, Xie H, Lefebre MD. Identification and molecular analysis of cable pilus biosynthesis genes in Burkholderia cepacia. Microbiology 2003, 149:961-971.
60. Corbett CR, Burtnick MN, Kooi C. An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology 2003, 149:2263-2271.
61. Flannagan RS, Valvano MA. Burkholderia cenocepacia requires RpoE for growth under stress conditions and delay of phagolysosomal fusion in macrophages. Microbiology 2008, 154:643-653.
62. Maloney KE, Valvano MA. The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun 2006, 74:5477-5486.
63. Flannagan RS, Aubert D, Kooi C. Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo. Infect Immun 2007, 75:1679-1689.
64. Reik R, Spilker T, Lipuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005, 43:2926-2928.
65. Brisse S, Cordevant C, Vandamme P. Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis. J Clin Microbiol 2004, 42:4824-4827.
66. Drevinek P, Cinek O, Melter J. Genomovar distribution of the Burkholderia cepacia complex differs significantly between Czech and Slovak patients with cystic fibrosis. J Med Microbiol 2003, 52:603-604.
67. Bevivino A, Dalmastri C, Tabacchioni S. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 2002, 40:846-851.
68. Cunha MV, Leitao JH, Mahenthiralingam E. Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol 2003, 41:4113-4120.
69. Huber B, Riedel K, Hentzer M. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 2001, 147:2517-2528.
70. Agnoli K, Lowe CA, Farmer KL. The ornibactin biosynthesis and transport genes of Burkholderia cenocepacia are regulated by an extracytoplasmic function sigma factor which is a part of the Fur regulon. J Bacteriol 2006, 188:3631-3644.
71. Sokol PA, Darling P, Woods DE. Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect Immun 1999, 67:4443-4455.
72. Sokol PA, Darling P, Lewenza S. Identification of a siderophore receptor required for ferric ornibactin uptake in Burkholderia cepacia. Infect Immun 2000, 68:6554-6560.
73. Chambers CE, Lutter EI, Visser MB. Identification of potential CepR regulated genes using a cep box motif-based search of the Burkholderia cenocepacia genome. BMC Microbiol 2006, 6:104.
74. Sousa SA, Moreira LM, Wopperer J. The Burkholderia cepacia bceA gene encodes a protein with phosphomannose isomerase and GDP-D-mannose pyrophosphorylase activities. Biochem Biophys Res Commun 2007, 353:200-206.
75. Ferreira AS, Leitao JH, Sousa SA. Functional analysis of Burkholderia cepacia genes bceD and bceF, encoding a phosphotyrosine phosphatase and a tyrosine autokinase, respectively: role in exopolysaccharide biosynthesis and biofilm formation. Appl Environ Microbiol 2007, 73:524-534.
76. Urban TA, Griffith A, Torok AM. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect Immun 2004, 72:5126-5134.
77. Urban TA, Goldberg JB, Forstner JF. Cable pili and the 22-kilodalton adhesin are required for Burkholderia cenocepacia binding to and transmigration across the squamous epithelium. Infect Immun 2005, 73:5426-5437.
78. Tomich M, Mohr CD. Adherence and autoaggregation phenotypes of a Burkholderia cenocepacia cable pilus mutant. FEMS Microbiol Lett 2003, 228:287-297.
79. Keith KE, Valvano MA. Characterization of SodC, a periplasmic superoxide dismutase from Burkholderia cenocepacia. Infect Immun 2007, 75:2451-2460.
80. Lefebre MD, Flannagan RS, Valvano MA. A minor catalase/peroxidase from Burkholderia cenocepacia is required for normal aconitase activity. Microbiology 2005, 151:1975-1985.
81. Aubert DF, Flannagan RS, Valvano MA. A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia. Infect Immun 2008, 76:1979-1991.
82. Huber B, Feldmann F, Kothe M. Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun 2004, 72:7220-7230.
83. Weingart CL, White CE, Liu S. Direct binding of the quorum sensing regulator CepR of Burkholderia cenocepacia to two target promoters in vitro. Mol Microbiol 2005, 57:452-467.